Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;10(7):1415.
doi: 10.3390/jcm10071415.

The Effect of Tranexamic Acid Administration on Early Endothelial Damage Following Posterior Lumbar Fusion Surgery

Affiliations

The Effect of Tranexamic Acid Administration on Early Endothelial Damage Following Posterior Lumbar Fusion Surgery

Hye Jin Kim et al. J Clin Med. .

Abstract

Tranexamic acid (TXA) protects against endothelial glycocalyx injury in vitro. We aimed to evaluate whether TXA could protect against endothelial glycocalyx degradation in patients undergoing posterior lumbar fusion surgery. Patients aged 30-80 years were enrolled. The TXA group was administered a loading dose of 10 mg/kg, followed by a 1 mg/kg/h infusion. Serum syndecan-1 and heparan sulfate concentrations, which are biomarkers of glycocalyx degradation, were measured at preoperative baseline (T0), immediately post-surgery (T1), and 2 h post-surgery (T2). Postoperative complications were assessed, including hypotension, desaturation, and acute kidney injury. Among the 121 patients who completed the study, 60 received TXA. There were no significant differences in the marker concentrations at each time point. However, the postoperative increase in syndecan-1 levels from baseline was significantly attenuated in the TXA group compared with the control group (median (interquartile range); T1 vs. T0: -1.6 (-5.3-2.6) vs. 2.2 (-0.7-4.8), p = 0.001; T2 vs. T0: 0.0 (-3.3-5.5) vs. 3.6 (-0.1-9.3), p = 0.013). Postoperative complications were significantly associated with the magnitude of the change in syndecan-1 levels (for T2 vs. T0: odds ratio: 1.08, 95% confidence interval: 1.02-1.14, p = 0.006). TXA administration was associated with reduced syndecan-1 shedding in patients undergoing posterior lumbar fusion surgery.

Keywords: endothelial glycocalyx; heparan sulfate; spinal surgery; syndecan-1; tranexamic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of patient enrollment.
Figure 2
Figure 2
The AUCs for predicting early postoperative complications based on perioperative changes in syndecan-1 concentrations. The AUC for the T0-T2 difference in serum syndecan-1 concentrations is 0.787 (95% CI: 0.663–0.911). In contrast, the AUC for the syndecan-1 concentration at T2 is 0.722 (95% CI: 0.561–0.884). AUC, area under the curve; CI, confidence interval; T0, preoperative baseline; T2, 2 h post-surgery.

References

    1. Bai J., Zhang P., Liang Y., Wang J., Wang Y. Efficacy and safety of tranexamic acid usage in patients undergoing posterior lumbar fusion: A meta-analysis. BMC Musculoskelet. Disord. 2019;20:390. doi: 10.1186/s12891-019-2762-2. - DOI - PMC - PubMed
    1. Reikeras O., Borgen P. Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma. PLoS ONE. 2014;9:e107881. doi: 10.1371/journal.pone.0107881. - DOI - PMC - PubMed
    1. Lindberg-Larsen V., Ostrowski S.R., Rovsing M.L., Johansson P.I., Kehlet H. The effect of pre-operative methylprednisolone on early endothelial damage after total knee arthroplasty: A randomised, double-blind, placebo-controlled trial. Anaesthesia. 2017;72:1217–1224. doi: 10.1111/anae.13983. - DOI - PubMed
    1. Cerny V., Astapenko D., Brettner F., Benes J., Hyspler R., Lehmann C., Zadak Z. Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine. Crit. Rev. Clin. Lab. Sci. 2017;54:343–357. doi: 10.1080/10408363.2017.1379943. - DOI - PubMed
    1. Martin L., Koczera P., Zechendorf E., Schuerholz T. The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis. BioMed Res. Int. 2016;2016:1–8. doi: 10.1155/2016/3758278. - DOI - PMC - PubMed

LinkOut - more resources